-
Mashup Score: 106Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk - 10 day(s) ago
Blood Cancer Journal – Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 103Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk - 12 day(s) ago
Blood Cancer Journal – Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 98Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk - 14 day(s) ago
Blood Cancer Journal – Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 51The molecular classification of multiple myeloma - PubMed - 2 month(s) ago
To better define the molecular basis of multiple myeloma (MM), we performed unsupervised hierarchic clustering of mRNA expression profiles in CD138-enriched plasma cells from 414 newly diagnosed patients who went on to receive high-dose therapy and tandem stem cell transplants. Seven disease subtype …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 36Rawha's Student Visionaries of the Year Fundraiser - 3 month(s) ago
I had the privilege of being nominated as a candidate for The Leukemia & Lymphoma Society’s (LLS) 2024 New York City Student Visionaries of the Year campaign. Student Visionaries of the Year is a seven-week leadership development program that runs from January 26th to March 15th to raise money to help blood cancer patients not only survive but thrive after treatment. I am writing today to ask for your support of my campaign and LLS’s mission to find a cure for blood cancers and improve the quality of life for patients. Growing up with my father being a hematologist oncologist and my mother an infectious diseases expert focused on blood cancer and stem cell transplants, I’ve learned the huge impact that cancer has on people’s lives. Whether it be dinner conversations or overhearing my parents on a work call, I always found interest in the topic of cancer. As a child, I remember participating in walks and 5ks with my family to raise awareness and money for blood cancer research.
Source: events.lls.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3MSK Awards & Appointments December 2023 - 4 month(s) ago
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments:Omar Abdel-Wahab Received the William Dameshek Prize from the American Society of Hematology
Source: www.mskcc.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Login - Integrity CE - 5 month(s) ago
Username* Password* Remember me Register | Forgot Password
Source: integrityce.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Multiple Myeloma Clinical Update #1 - 5 month(s) ago
Gain key insights on multiple myeloma from expert faculty! Saad Z. Usmani, MD, MBA, FACP, FRCP, Ajay Nooka, MD, MPH, & Joshua Richter, MD will discuss updated results from the CARTITUDE-2 trial.Follow along on Twitter @SoMeCME using the hashtag #MMUpdate
Source: www.addevent.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 23Assistant/Associate Attending Physician Myeloma Service - New York City, New York (US) - 5 month(s) ago
We are seeking full-time faculty members at the assistant attending level for clinical service, teaching, and research.
Source: careercenter.asco.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 23Assistant/Associate Attending Physician Myeloma Service - New York City, New York (US) - 5 month(s) ago
We are seeking full-time faculty members at the assistant attending level for clinical service, teaching, and research.
Source: careercenter.asco.orgCategories: General Medicine News, Hem/OncsTweet
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk | Blood Cancer Journal #mmsm @ALLIANCE_org @PlasmaCellPete @nsc_natalie @MSKCancerCenter https://t.co/PMrYBn8Ndb